Cevostamab (Anti- FcRH5 / IRTA2 / CD307e)
Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) (A2746-GRP)
Products
Description
Cevostamab (Anti- FcRH5 / IRTA2 / CD307e) is a humanized IgG1-based bispecific antibody that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. MW: 145.24 kD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2746 |